DRIO Stock Analysis: Buy, Sell, or Hold?
DRIO - DarioHealth Corp. Common Stock
$8.39
0.29 (3.52%)
▲
5d:
+3.2%
30d:
+11.65%
90d:
-23.77%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When DRIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DRIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: DRIO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DRIO is currently trading at $8.38, which is considered extended relative to its 30-day fair value range of $7.05 to $7.98.
Technical Outlook: Technically, DRIO is in a strong downtrend. Immediate support is located at $7.20, while resistance sits at $8.81. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: DRIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.50 (+120.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DRIO is in a strong downtrend. Immediate support is located at $7.20, while resistance sits at $8.81. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: DRIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.50 (+120.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.05 -
$7.98
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 120.6% below Wall St target ($18.50)
Trading Range Analysis
30-Day Trading Range
$7.05 -
$7.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.20
Resistance Level
$8.81
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.28
Wall Street Target
$18.50
(+120.6%)
Revenue Growth (YoY)
-31.2%
Profit Margin
-186.6%
Share & Embed Analysis
Last updated: May 15, 2026 6:54 AM ET
Data refreshes hourly during market hours. Next update: 7:54 AM
Data refreshes hourly during market hours. Next update: 7:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DRIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 54 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |
